A team of US-based scientists has described the therapeutic efficacy of a pan-Orthopoxvirus inhibitor, tecovirimat, in patients with monkeypox infection
from The Medical News https://ift.tt/6SsIrd5
from The Medical News https://ift.tt/6SsIrd5